Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study
Assya Akli, Nicolas Girard, Vincent Fallet, G. Rousseau-Bussac, V. Gounant, S. Friard, Jean Trédaniel, C. Dujon, Marie Wislez, Boris Duchemann, Etienne Giroux‐Leprieur
Topics & Concepts
OsimertinibMedicineLung cancerInternal medicineEpidermal growth factor receptorOncologyProgression-free survivalAdenocarcinomaDiscontinuationMetastasisTumor progressionT790MBrain metastasisTyrosine-kinase inhibitorCancer researchCancerErlotinibChemotherapyGefitinibLung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and Treatment